CLINICAL_TRIALS
trial_result
· 2022-03-17
Clinical Trial Update: Famciclovir in Multiple Sclerosis [Phase 2]
Summary
Phase 2 clinical trial update for famciclovir in multiple sclerosis is ongoing with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Queen Mary University of London | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN